Novartis raises full-year targets, aims to settle U.S. lawsuit
July 18, 2019 at 05:59 AM EDT
Novartis boss Vas Narasimhan raised full-year targets on Thursday and announced that $700 million has been set aside in the hope of settling a decade-old lawsuit alleging that the Swiss drugmaker bribed U.S. doctors.
